Pages that link to "Q36558691"
Jump to navigation
Jump to search
The following pages link to Wnt/β-catenin signaling is hyperactivated in systemic sclerosis and induces Smad-dependent fibrotic responses in mesenchymal cells (Q36558691):
Displaying 50 items.
- Endothelial to Mesenchymal Transition (EndoMT) in the Pathogenesis of Human Fibrotic Diseases (Q26748338) (← links)
- Vascular Remodelling and Mesenchymal Transition in Systemic Sclerosis (Q26749091) (← links)
- Emerging Role and Therapeutic Implication of Wnt Signaling Pathways in Autoimmune Diseases (Q26750589) (← links)
- MicroRNAs Regulating Signaling Pathways: Potential Biomarkers in Systemic Sclerosis (Q26781257) (← links)
- Signaling in Fibrosis: TGF-β, WNT, and YAP/TAZ Converge (Q26782820) (← links)
- Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells (Q26851971) (← links)
- Dissecting the heterogeneity of skin gene expression patterns in systemic sclerosis (Q30845649) (← links)
- Identification of cadherin 11 as a mediator of dermal fibrosis and possible role in systemic sclerosis (Q34133158) (← links)
- Genome-wide DNA methylation analysis in dermal fibroblasts from patients with diffuse and limited systemic sclerosis reveals common and subset-specific DNA methylation aberrancies (Q34475490) (← links)
- Wnt coreceptor Lrp5 is a driver of idiopathic pulmonary fibrosis (Q34480454) (← links)
- A Wnt-TGFβ2 axis induces a fibrogenic program in muscle stem cells from dystrophic mice (Q35150743) (← links)
- Sustained β-catenin activity in dermal fibroblasts promotes fibrosis by up-regulating expression of extracellular matrix protein-coding genes (Q35171136) (← links)
- Fibrosis in systemic sclerosis: common and unique pathobiology (Q36012572) (← links)
- Regulation of Matrix Remodeling by Peroxisome Proliferator-Activated Receptor-γ: A Novel Link Between Metabolism and Fibrogenesis (Q36093802) (← links)
- Role of glycogen synthase kinase-3β and PPAR-γ on epithelial-to-mesenchymal transition in DSS-induced colorectal fibrosis (Q36282521) (← links)
- 2-Amino-4-(3,4-(methylenedioxy)benzylamino)-6-(3-methoxyphenyl)pyrimidine is an anti-inflammatory TLR-2, -4 and -5 response mediator in human monocytes (Q36437070) (← links)
- Targeting miR-155 to Treat Experimental Scleroderma (Q36524910) (← links)
- Adiponectin inhibits Wnt co-receptor, Lrp6, phosphorylation and β-catenin signaling (Q36563098) (← links)
- Role of endothelial to mesenchymal transition in the pathogenesis of the vascular alterations in systemic sclerosis (Q37224668) (← links)
- Morphogen pathways in systemic sclerosis (Q38071976) (← links)
- Molecular basis of organ fibrosis: potential therapeutic approaches (Q38121751) (← links)
- What does global gene expression profiling tell us about the pathogenesis of systemic sclerosis? (Q38141638) (← links)
- Canonical Wnt signalling as a key regulator of fibrogenesis - implications for targeted therapies? (Q38151902) (← links)
- Novel investigational agents for the treatment of scleroderma (Q38164818) (← links)
- Fibrosis--a lethal component of systemic sclerosis (Q38206104) (← links)
- Integrins and cadherins as therapeutic targets in fibrosis (Q38219401) (← links)
- Molecular and cellular basis of scleroderma (Q38230276) (← links)
- Stroma as an Active Player in the Development of the Tumor Microenvironment (Q38238231) (← links)
- Current frontiers in systemic sclerosis pathogenesis. (Q38364957) (← links)
- Unfolding the pathogenesis of scleroderma through genomics and epigenomics (Q38681645) (← links)
- Critical Appraisal of the Utility and Limitations of Animal Models of Scleroderma (Q38681751) (← links)
- Canonical Wnt signaling in systemic sclerosis (Q38692353) (← links)
- Endothelial to mesenchymal transition (EndoMT) in the pathogenesis of Systemic Sclerosis-associated pulmonary fibrosis and pulmonary arterial hypertension. Myth or reality? (Q38710580) (← links)
- Two-Way Conversion between Lipogenic and Myogenic Fibroblastic Phenotypes Marks the Progression and Resolution of Lung Fibrosis. (Q39170625) (← links)
- Hepatocellular Carcinoma-propagating Cells are Detectable by Side Population Analysis and Possess an Expression Profile Reflective of a Primitive Origin (Q39304072) (← links)
- Activation of Wnt/β-catenin signalling is required for TGF-β/Smad2/3 signalling during myofibroblast proliferation (Q41241209) (← links)
- Cytoskeleton and nuclear lamina affection in recessive osteogenesis imperfecta: A functional proteomics perspective. (Q41616038) (← links)
- Targeted inhibition of disheveled PDZ domain via NSC668036 depresses fibrotic process (Q41760157) (← links)
- Connective tissue disease: SSc-fibrosis takes flight with Wingless inhibition. (Q42133126) (← links)
- Sustained β-Catenin Activity in Dermal Fibroblasts Is Sufficient for Skin Fibrosis (Q42158169) (← links)
- WNT/β-catenin signaling induces IL-1β expression by alveolar epithelial cells in pulmonary fibrosis (Q43890213) (← links)
- TGF-β-Induced Endothelial-Mesenchymal Transition in Fibrotic Diseases. (Q44537770) (← links)
- Synovialitis of the arthrofibrotic type: criteria of a new synovialitis type for the diagnosis of arthrofibrosis (Q44684035) (← links)
- Inactivation of evenness interrupted (EVI) reduces experimental fibrosis by combined inhibition of canonical and non-canonical Wnt signalling (Q46121852) (← links)
- The Tension Biology of Wound Healing. (Q46128858) (← links)
- Inactivation of tankyrases reduces experimental fibrosis by inhibiting canonical Wnt signalling (Q46942177) (← links)
- Interactions between TGF-β1, canonical WNT/β-catenin pathway and PPAR γ in radiation-induced fibrosis (Q47109863) (← links)
- Decoy Wnt receptor (sLRP6E1E2)-expressing adenovirus induces anti-fibrotic effect via inhibition of Wnt and TGF-β signaling (Q47117290) (← links)
- Thermodynamic Aspects and Reprogramming Cellular Energy Metabolism during the Fibrosis Process (Q47282821) (← links)
- Inhibition of β-Catenin Signaling in the Skin Rescues Cutaneous Adipogenesis in Systemic Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Trial of C-82. (Q47954120) (← links)